BCL-2 Family Proteins as Therapeutic Targets in Multiple Myeloma - Episode 9

Other Investigational Agents Targeting BCL-2 Family Proteins for Multiple Myeloma Treatment


Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. An explanation of the focus on BCL-2 inhibitors versus the development of MCL-1 inhibitors for multiple myeloma treatment.